BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
20.77
+0.78 (3.90%)
At close: Jun 18, 2026, 4:00 PM EDT
20.18
-0.59 (-2.84%)
After-hours: Jun 18, 2026, 6:56 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $923.28 million as of June 18, 2026. Its market cap has increased by 503.14% in one year.
Market Cap
923.28M
Enterprise Value
542.44M
1-Year Change
503.14%
Ranking
Category
Stock Price
$20.77
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $923.28M, an increase of 50.13%. That is a compound annual growth rate of 26.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 923.28M | 94.64% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 1.42B |
| Phibro Animal Health | 1.29B |
| Alvotech | 1.22B |
| Xeris Biopharma Holdings | 1.20B |
| Collegium Pharmaceutical | 1.09B |
| Cronos Group | 1.02B |
| Evotec SE | 925.77M |
| Eton Pharmaceuticals | 889.70M |